Mauro Piantelli
Mauro Piantelli
CeSI-Met Foundation, Chieti-Pescara University, Italy
Email verificata su unich.it
Titolo
Citata da
Citata da
Anno
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
S Caltagirone, C Rossi, A Poggi, FO Ranelletti, PG Natali, M Brunetti, ...
International Journal of Cancer 87 (4), 595-600, 2000
5512000
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target
G Scambia, FO Ranelletti, PB Panici, R De Vincenzo, G Bonanno, ...
Cancer chemotherapy and pharmacology 34 (6), 459-464, 1994
3371994
Quercetin inhibits p21‐RAS expression in human colon cancer cell lines and in primary colorectal tumors
FO Ranelletti, N Maggiano, FG Serra, R Ricci, LM Larocca, P Lanza, ...
International journal of cancer 85 (3), 438-445, 2000
1962000
Growth‐inhibitory effect of quercetin and presence of type‐II estrogen‐binding sites in human colon‐cancer cell lines and primary colorectal tumors
FO Ranelletti, R Ricci, LM Larocca, N Maggiano, A Capelli, G Scambia, ...
International Journal of Cancer 50 (3), 486-492, 1992
1961992
90K (Mac-2 BP) and galectins in tumor progression and metastasis
A Grassadonia, N Tinari, I Iurisci, E Piccolo, A Cumashi, P Innominato, ...
Glycoconjugate journal 19 (7-9), 551-556, 2002
1812002
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells
G Scambia, FO Ranelletti, PB Panici, M Piantelli, G Bonanno, ...
British journal of cancer 62 (6), 942-946, 1990
1561990
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice
C Corona, V Frazzini, E Silvestri, R Lattanzio, R La Sorda, M Piantelli, ...
PloS one 6 (3), e17971, 2011
1502011
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites
G Scambia, FO Ranelletti, PB Panici, M Piantelli, G Bonanno, ...
Cancer chemotherapy and pharmacology 28 (4), 255-258, 1991
1461991
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes
M Brunetti, N Martelli, A Colasante, M Piantelli, P Musiani, FB Aiello
1401995
Phospholipase Cγ1 is required for metastasis development and progression
G Sala, F Dituri, C Raimondi, S Previdi, T Maffucci, M Mazzoletti, C Rossi, ...
Cancer research 68 (24), 10187-10196, 2008
1312008
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction
C Corona, F Masciopinto, E Silvestri, A Del Viscovo, R Lattanzio, ...
Cell death & disease 1 (10), e91-e91, 2010
1302010
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer
S Caltagirone, FO Ranelletti, A Rinelli, N Maggiano, A Colasante, ...
American journal of respiratory cell and molecular biology 17 (1), 51-59, 1997
1231997
Upregulation of Trop-2 quantitatively stimulates human cancer growth
M Trerotola, P Cantanelli, E Guerra, R Tripaldi, AL Aloisi, V Bonasera, ...
Oncogene 32 (2), 222-233, 2013
1172013
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships.
R De Vincenzo, G Scambia, PP Benedetti, FO Ranelletti, G Bonanno, ...
Anti-cancer drug design 10 (6), 481, 1995
1081995
Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth
G Scambia, FO Ranelletti, PB Panici, G Bonanno, R De Vincenzo, ...
Anti-cancer drugs 1 (1), 45-48, 1990
1051990
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.
G Scambia, G Ferrandina, M Marone, P Benedetti Panici, C Giannitelli, ...
Journal of clinical oncology 14 (2), 334-342, 1996
981996
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients
P Querzoli, M Pedriali, R Rinaldi, AR Lombardi, E Biganzoli, P Boracchi, ...
Clinical cancer research 12 (22), 6696-6701, 2006
952006
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids
LM Larocca, M Piantelli, G Leone, S Sica, L Teofili, PB Panici, G Scambia, ...
British journal of haematology 75 (4), 489-495, 1990
951990
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)
G Scambia, FO Ranelletti, PB Panici, M Piantelli, G Bonanno, ...
Gynecologic oncology 45 (1), 13-19, 1992
941992
CD133, Trop-2 and α2β1 integrin surface receptors as markers of putative human prostate cancer stem cells
M Trerotola, S Rathore, HL Goel, J Li, S Alberti, M Piantelli, D Adams, ...
American journal of translational research 2 (2), 135, 2010
912010
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20